Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EXEL
#731
Exelixis, Inc. - Common Stock
56.0
4
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.81%
Monthly Change
+5.14%
6 month change
+23.16%
Year Change
+43.55%
Previous Close
56.5
0
Open
56.0
4
Low
56.0
4
High
56.0
4
Volume
267
Markets
US Stock Market
Healthcare
Biotechnology
EXEL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Current
Key stats
Total common shares outstanding
251.36 M
251.36 M
Valuation ratios
Enterprise value
10.83 B
13.89 B
Price to earnings ratio
14.56
18.6
Price to sales ratio
5.14
6.57
Price to cash flow ratio
13.17
16.82
Price to book ratio
1.47
1.88
Enterprise value to EBITDA ratio
11.22
14.39
Profitability ratios
Return on assets %
0.08
0.08
Return on equity %
0.11
0.11
Return on invested capital %
45.96
45.96
Gross margin %
96.73
96.73
Operating margin %
41.15
41.15
EBITDA margin %
42.29
42.29
Net margin %
34.46
34.46
Liquidity ratios
Quick ratio
3.19
3.19
Current ratio
3.26
3.26
Inventory turnover
0.83
0.83
Asset turnover
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
0.94
3.34
EBIT per share
0.94
3.37
EBITDA per share
0.97
3.48
Total debt per share
—
—
Cash per share
2.91
2.91
Net current asset value per share
4.52
4.52
Tangible book value per share
7.24
7.24
Working capital per share
3.13
3.13
Book value per share
7.24
7.24
News
Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?
Stocks Look Shaky, But This Sector is Booming (Biotech)
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Exelixis: STELLAR-303 Results Mixed, STELLAR-304 Success Likely (NASDAQ:EXEL)
EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?
Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?
Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists
Arista Networks, Morgan Stanley Among 15 New Stocks On IBD Watchlists
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
GE Aerospace Hits Record High, Leads 19 Onto IBD 50, Big Cap 20, Other Best Stock Lists